Articles scientifiques

Societal challenges of precision medicine: Bringing order to chaos.

Auteurs : Salgado R, Moore H, Martens JWM, Lively T, Malik S, McDermott MW, Michiels S, Moscow JA, Tejpar S, Lacombe D
Année : 2017
Journal : Eur J Cancer
Volume : 84
Pages : 325-334

Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study.

Auteurs : Pellanda AF, De Bari B, Deniaud-Alexandre E, Krengli M, Van Houtte P, Richetti A, Villà S, Goldberg H, Bolla M, Rutten H, Van Eijkeren M, Poortmans P, Henke G, Anacak Y, Chan S, Landmann C, Kirkove C, Scandolaro L, Bernier J, Mirimanoff RO, Ozsahin M
Année : 2017
Journal : Chin J Cancer Res
Volume : 29
Pages : 521-532

Corrigendum to 3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259]."

Auteurs : Cardoso F, Costa A, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Bhattacharyya G, Biganzoli L, Cardoso MJ, Carey L, Corneliussen-James D, Curigliano G, Dieras V, El Saghir N, Eniu A, Fallowfield L, Fenech D, Francis P, Gelmon K, Gennari A, Harbeck N, Hudis C, Kaufman B, Krop I, Mayer M, Meijer H, Mertz S, Ohno S, Pagani O, Papadopoulos E, Peccatori F, Penault-Llorca F, Piccart-Gebhart M, Pierga JY, Rugo H, Shockney L, Sledge G, Swain S, Thomssen C, Tutt A, Vorobiof D, Xu B, Norton L, Winer E
Année : 2017
Journal : Breast
Volume : 32
Pages : 269-270

Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia.

Auteurs : Stamatopoulos B, Timbs A, Bruce D, Smith T, Clifford R, Robbe P, Burns A, Vavoulis DV, Lopez L, Antoniou P, Mason J, Dreau H, Schuh A
Année : 2017
Journal : Leukemia
Volume : 31(4)
Pages : 837-45

Editorial.

Auteurs : Berghmans T
Année : 2017
Journal : Rev Med Brux
Volume : 38
Pages : 3

Genomic Evolution of Breast Cancer Metastasis and Relapse.

Auteurs : Yates LR, Knappskog S, Wedge D, Farmery JHR, Gonzalez S, Martincorena I, Alexandrov LB, Van Loo P, Haugland HK, Lilleng PK, Gundem G, Gerstung M, Pappaemmanuil E, Gazinska P, Bhosle SG, Jones D, Raine K, Mudie L, Latimer C, Sawyer E, Desmedt C, Sotiriou C, Stratton MR, Sieuwerts AM, Lynch AG, Martens JW, Richardson AL, Tutt A, Lønning PE, Campbell PJ
Année : 2017
Journal : Cancer Cell
Volume : 32
Pages : 169-184.e7

Data on HO-1 and CD200 protein secretion during T-cells and mesenchymal stromal cells co-cultures.

Auteurs : Fayyad-Kazan M, Fayyad-Kazan H, Merimi M, Meuleman N, Bron D, Lagneaux L, Najar M
Année : 2017
Journal : Data Brief
Volume : 11
Pages : 442-445

Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies.

Auteurs : Lambertini M, Ceppi M, Cognetti F, Cavazzini G, De Laurentiis M, De Placido S, Michelotti A, Bisagni G, Durando A, Valle E, Scotto T, De Censi A, Turletti A, Benasso M, Barni S, Montemurro F, Puglisi F, Levaggi A, Giraudi S, Bighin C, Bruzzi P, Del Mastro L
Année : 2017
Journal : Eur J Cancer
Volume : 71
Pages : 34-42

P53 and MITF/Bcl-2 identified as key pathways in the acquired resistance of NRAS-mutant melanoma to MEK inhibition.

Auteurs : Najem A, Krayem M, Sales F, Hussein N, Badran B, Robert C, Awada A, Journe F, Ghanem G
Année : 2017
Journal : Eur J Cancer
Volume : 83
Pages : 154-165

Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.

Auteurs : Gingras I, Holmes E, de Azambuja E, Nguyen DH, Izquierdo M, Anne Zujewski J, Inbar M, Naume B, Tomasello G, Gralow JR, Wolff AC, Harris L, Gnant M, Moreno-Aspitia A, Piccart-Gebhart M, Azim HA Jr
Année : 2017
Journal : J Natl Cancer Inst
Volume : 109

Foreskin as a source of immunotherapeutic mesenchymal stromal cells.

Auteurs : Najar M, Lagneaux L
Année : 2017
Journal : Immunotherapy
Volume : 9(2)
Pages : 207-217

Mediastinal Grey Zone Lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the LYSA.

Auteurs : Sarkozy C, Molina T, Ghesquières H, Michallet AS, Dupuis J, Damotte D, Morsschauser F, Parrens M, Martin L, Dartigues P, Stamatoullas A, Hirsch P, Fabiani B, Bouabdallah K, Gomes Da Silva M, Maerevoet M, Laurent C, Coiffier B, Salles G, Traverse-Glehen A
Année : 2017
Journal : Haematologica
Volume : 102(1)
Pages : 150-9

The PREgnancy and FERtility (PREFER) study: an Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients.

Auteurs : Lambertini M, Anserini P, Fontana V, Poggio F, Iacono G, Abate A, Levaggi A, Miglietta L, Bighin C, Giraudi S, DAlonzo A, Blondeaux E, Buffi D, Campone F, Merlo DF, Del Mastro L
Année : 2017
Journal : BMC Cancer
Volume : 17
Pages : 346

Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE).

Auteurs : Loibl S, de la Pena L, Nekljudova V, Zardavas D, Michiels S, Denkert C, Rezai M, Bermejo B, Untch M, Lee SC, Turri S, Urban P, Kümmel S, Steger G, Gombos A, Lux M, Piccart-Gebhart M, Von Minckwitz G, Baselga J, Loi S
Année : 2017
Journal : Eur J Cancer
Volume : 85
Pages : 133-145

Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel?

Auteurs : Van Praet C, Rottey S, Van Hende F, Pelgrims G, Demey W, Van Aelst F, Wynendaele W, Gil T, Schatteman P, Filleul B, Schallier D, Machiels JP, Schrijvers D, Everaert E, DHondt L, Werbrouck P, Vermeij J, Mebis J, Clausse M, Rasschaert M, Van Erps J, Verheezen J, Van Haverbeke J, Goeminne JC, Lumen N
Année : 2017
Journal : Clin Genitourin Cancer
Volume : 15(4)
Pages : 502-508

PolyI:C and CpG synergize with anti-ErbB2 mAb for treatment of breast tumors resistant to immune checkpoint inhibitors.

Auteurs : Charlebois R, Allard B, Allard D, Buisseret L, Turcotte M, Pommey S, Chrobak P, Stagg J
Année : 2017
Journal : Cancer Res
Volume : 77(2)
Pages : 312-9

Immunotherapy and non-small cell lung cancer : a (r)evolution.

Auteurs : Berghmans T, Meert AP
Année : 2017
Journal : Rev Med Brux
Volume : 38
Pages : 175-177

A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer.

Auteurs : Baselga J, Morales SM, Awada A, Blum JL, Tan AR, Ewertz M, Cortes J, Moy B, Ruddy KJ, Haddad T, Ciruelos EM, Vuylsteke P, Ebbinghaus S, Im E, Eaton L, Pathiraja K, Gause C, Mauro D, Jones MB, Rugo HS
Année : 2017
Journal : Breast Cancer Res Treat
Volume : 163(3)
Pages : 535-544

Monitoring molecular response in adult T-cell leukemia by high-throughput sequencing analysis of HTLV-1 clonality.

Auteurs : Artesi M, Marçais A, Durkin K, Rosewick N, Hahaut V, Suarez F, Trinquand A, Lhermitte L, Asnafi V, Avettand-Fenoel V, Burny A, Georges M, Hermine O, Van den Broeke A
Année : 2017
Journal : Leukemia
Volume : 31
Pages : 2532-35

Sequential tumor-directed and lobar radioembolization before major hepatectomy for hepatocellular carcinoma.

Auteurs : Vouche M, Degrez T, Bouazza F, Delatte P, Gomez Galdon M, Hendlisz A, Flamen P, Donckier V
Année : 2017
Journal : World J Hepatol
Volume : 9
Pages : 1372-1377